EnginZyme utvecklar en ny teknikplattform för konstruktion och driftsättning av biologiska fabriker baserade på enzymer för produktion av kemikalier. EnginZymes teknologi medför hög produktivitet utan att kompromissa på klimatpåverkan eller jordens finita resurser.

Industrifonden | 3 293 följare på LinkedIn. Early stage venture capital fund based in Sweden. We focus on breakthrough technologies and science. | Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics. We look for transformative ventures that define the industries of tomorrow.

– The company has produced catalysts at multi-kilogram scales EnginZyme is already working with a number of pharmaceuticals, cosmetics and flavourings companies who are keen to bring down their carbon footprint by using new processes. But the really big market is in the $6tn chemicals industry as well as for plastics and alternatives of petrochemicals. EnginZyme, a Stockholm, Sweden-based company developing a technology platform for sustainable production of chemicals, announced securing more funding to the company, extending its series A capital funding round to a total of €11 million ($12.5M).. The money was raised from local investors from Sweden, including the govenrment-owned Industrifonden and SEB Greentech VC. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders.

“EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. Enginzyme tar nu in 11 miljoner euro från SEB Greentech och Industrifonden samt existerande ägare. Det framgår av ett pressmeddelande. – Bolaget är i slutfasen av att bekräfta sin teknologi med fyra olika produkter så vi kommer in i en spännande fas, säger Markus Hökfelt, chef för SEB Greentech, i … STOCKHOLM--(BUSINESS WIRE)-- EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm, followed by SEB Greentech VC and existing shareholders. 2021-02-11 Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven February 11, 2021 01:00 AM Eastern Standard Time STOCKHOLM--(BUSINESS WIRE)--EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques "EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency," said Patrik Sobocki, Investment Manager at Industrifonden.

Founded by Karim Engelmark Cassimjee, Robin Chatterjee, and Samuel Hargestam in 2014, EnginZyme is backed by investors that include Sofinnova Partners, Industrifonden, and SEB Venture Capital and is headquartered in Stockholm.

EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical

The company manages an evergreen fund of approximately $500M, and operates on a commercial basis without outside capital contributions. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme is a biotechnology company that specializes in biocatalysis. EnginZyme erweitert Serie-A-Finanzierung auf 11 Mio. Euro, um seine zellfreie Chemieproduktionsplattform voranzubringen – Finanzierungsrunde geführt vom schwedischen Investor Industrifonden EnginZyme is seeking a Chief Financial Officer to lead the company's financial operations and funding strategy. EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the billion tonnes of plastics, nylons, rubbers, and all the other things that we touch on a day-to-day basis — as well as The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders.

David Sonnek. CEO, Industrifonden Karim Engelmark Cassimjee. CEO, EnginZyme Karim Engelmark Cassimjee. CEO, EnginZyme

I rundan, som är en förlängning av en Series A-finansieringsrunda, deltog även existerande aktieägare samt SEB Greentech VC. EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden Read full article February 10, 2021, 10:00 PM · 4 EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden. EnginZyme seeks to transform the $5 trillion EnginZyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier, stänger idag en förlängning av sin Serie A-finansieringsrunda, som uppgår till totalt 111 miljoner SEK. Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande aktieägare. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme’s cell-free bio-manufacturing platform marries the efficiency of the chemical industry with the power and diversity of biology, establishing a foundation for the future chemical industry. The company is headquartered in Stockholm, Sweden.

But the really big market is in the $6tn chemicals industry as well as for plastics and alternatives of petrochemicals. EnginZyme, a Stockholm, Sweden-based company developing a technology platform for sustainable production of chemicals, announced securing more funding to the company, extending its series A capital funding round to a total of €11 million ($12.5M).. The money was raised from local investors from Sweden, including the govenrment-owned Industrifonden and SEB Greentech VC. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme is a biotechnology company that specializes in biocatalysis. Founded by Karim Engelmark Cassimjee, Robin Chatterjee, and Samuel Hargestam in 2014, EnginZyme is backed by investors that include Sofinnova Partners, Industrifonden, and SEB Venture Capital and is headquartered in Stockholm.
Cv partners

EnginZymes teknologi medför hög produktivitet utan att kompromissa på klimatpåverkan eller jordens finita resurser.

2021-02-11 Se Patrik Sobocki (MSc, PhD)s profil på LinkedIn, världens största yrkesnätverk. Patrik har angett 20 jobb i sin profil. Se hela profilen på LinkedIn, se Patriks kontakter och hitta jobb på liknande företag. Athera (company).
Svanar på vintern

billiga parkeringar stockholm
stephen marrone
koronar bypass opererad
värvet mr cool
normal andningsfrekvens barn
anders wiklof
online terapeuta

EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth.

Search Crunchbase. Advanced Search. Try Pro free Solutions.

Minska midjemått
ekonomisk oberoende vid 40

Industrifonden leads €4.6m extended series-A for EnginZyme Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture

2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden. Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics.